Preparing your space
Preparing your space
Conditions & Recovery · ASCO Daily News · March 19, 2026
![]({"$":{"href":"https://static.libsyn.com/p/assets/7/b/2/f/7b2f0144e4518357d959afa2a1bf1c87/ASCO_Daily_News-Podcast-Icon26_1.png"}})
Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like FLAURA2, novel drug therapies, and the growing importance of ctDNA and MRD testing. TRANSCRIPT Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist and professor and vice chair of
Originally published by ASCO Daily News. We curate and add context; they did the reporting.
Read the full story at ASCO Daily News ↗